Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector Version

Sanofi, Cipla collaborate to expand Central Nervous System portfolio reach in India

Written By Ruchika Sharma28 March 2024 4:48 PM IST

Mumbai: Sanofi India Limited and Sanofi Healthcare India Private Limited, and Cipla Limited have announced an exclusive partnership for...

Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial Metrics

Biocon obtains approval for diabetes drug Liraglutide in UK

Written By Ruchika Sharma28 March 2024 2:30 PM IST

Bengaluru: Biocon Limited, a global biopharmaceuticals company, has announced that the Company has received approval from the Medicines and...

AstraZeneca Gets SEC Nod to Update Lokelma Prescribing Information for Hyperkalemia Treatment

AstraZeneca India bags dual CDSCO nod for Trastuzumab deruxtecan

Written By Ruchika Sharma28 March 2024 1:30 PM IST

Bangalore: AstraZeneca Pharma India Limited has received permission to import for sale and distribution of Trastuzumab deruxtecan lyophilized...

USFDA inspection: Zydus Lifesciences gets 4 observations for Ahmedabad plant

Written By Ruchika Sharma28 March 2024 12:30 PM IST

Ahmedabad: Zydus Lifesciences has announced that the Company has received four observations from the U.S. Food and Drug Administration (USFDA) at...

USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three Observations

USFDA issues ten observations for Alkem Labs Baddi facility

Written By Ruchika Sharma28 March 2024 11:29 AM IST

Mumbai: Alkem Labs has announced that the U.S. Food and Drug Administration (USFDA) has issued Form 483 with ten observations at the...

Quadria Capital-Led Consortium Eyes Majority Stake in Samarth Lifesciences at Rs 4,500 Cr Valuation

Novo Nordisk to acquire Cardior Pharma for up to 1.025 billion Euros

Written By Ruchika Sharma27 March 2024 1:30 PM IST

Denmark Novo Nordisk and Cardior Pharmaceuticals have announced that Novo Nordisk has agreed to acquire Cardior for up to 1.025 billion Euros,...

Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid Tariffs

USFDA grants Fast Track designation to JnJ nipocalimab to reduce fetal neonatal alloimmune thrombocytopenia risk in alloimmunized pregnant adults

Written By Ruchika Sharma27 March 2024 12:30 PM IST

Spring House: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation (FTD) for...

USFDA Approves Corcept Therapeutics Ovarian Cancer Drug Lifyorli

Merck gets USFDA nod for WINREVAIR (sotatercept-csrk) for adults with pulmonary arterial hypertension

Written By Ruchika Sharma27 March 2024 11:51 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved...

Indoco Remedies arm begins commercial production of Pharmaceutical Intermediates

Written By Ruchika Sharma26 March 2024 3:30 PM IST

Mumbai: Warren Remedies Private Limited, a Wholly Owned Subsidiary of Indoco Remedies Limited has commenced its commercial production from its...

AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosus

AstraZeneca Ultomiris gets USFDA approval for adults with neuromyelitis optica spectrum disorder

Written By Ruchika Sharma26 March 2024 12:52 PM IST

Ultomiris, a long-acting C5 complement inhibitor, provides immediate, complete and sustained complement inhibition.

Prior Intimation System Under NDCT Rules Wont Apply to Hormones, Cytotoxics, Beta-Lactams, Certain Biologics: CDSCO

Bharat Biotech begins clinical trial of Tuberculosis vaccine MTBVAC in India

Written By Ruchika Sharma26 March 2024 12:34 PM IST

Hyderabad: Clinical trials of MTBVAC, the Spanish tuberculosis vaccine, the first live attenuated vaccine of Mycobacterium tuberculosis isolated...

Shilpa Biologicals, Stein Cares Ink Exclusive Biosimilar Licensing Pact for Latin America

Bayer, Thermo Fisher Scientific join hands to increase patient access to precision cancer medicines

Written By Ruchika Sharma25 March 2024 12:30 PM IST

Berlin: Bayer AG and Thermo Fisher Scientific Inc. have announced a collaboration to develop next-generation sequencing (NGS)-based companion...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok